Drug Profile
Human papillomavirus vaccine recombinant octavalent - Merck
Alternative Names: Octavalent HPV VLP vaccine - Merck; Octavalent human papillomavirus (types 6, 11, 16, 18, 31, 45, 52, and 58) L1 virus-like particle vaccine - Merck; V-502Latest Information Update: 10 Feb 2014
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Cancer vaccines; Papillomavirus vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cervical cancer; Human papillomavirus infections
Most Recent Events
- 10 Feb 2014 Discontinued - Phase-I for Cervical cancer in Australia (IM)
- 10 Feb 2014 Discontinued - Phase-I for Cervical cancer in USA (IM)
- 10 Feb 2014 Discontinued - Phase-I for Human papillomavirus infections in Australia (IM)